Pre-treatment with Mycobacterium avium-derived lipids reduces the macrophage response to interferon γ in BCG-vaccinated mice

References

1. Bekker L. G., Moreira A. L., Bergtold A., Freeman S., Ryffel B., Kaplan G. 2000; Immunopathologic effects of tumor necrosis factor alpha in murine mycobacterial infection are dose dependent. Infect Immun 68:6954–6961 [View Article][PubMed]
   [Google Scholar]
2. Buddle B. M., Wards B. J., Aldwell F. E., Collins D. M., de Lisle G. W. 2002; Influence of sensitisation to environmental mycobacteria on subsequent vaccination against bovine tuberculosis. Vaccine 20:1126–1133 [View Article][PubMed]
   [Google Scholar]
3. de Lisle G. W., Wards B. J., Buddle B. M., Collins D. M. 2005; The efficacy of live tuberculosis vaccines after presensitization with Mycobacterium avium . Tuberculosis (Edinb) 85:73–79 [View Article][PubMed]
   [Google Scholar]
4. Demangel C., Garnier T., Rosenkrands I., Cole S. T. 2005; Differential effects of prior exposure to environmental mycobacteria on vaccination with Mycobacterium bovis BCG or a recombinant BCG strain expressing RD1 antigens. Infect Immun 73:2190–2196 [View Article][PubMed]
   [Google Scholar]
5. Ehlers S., Kutsch S., Benini J., Cooper A., Hahn C., Gerdes J., Orme I., Martin C., Rietschel E. T. 1999; NOS2-derived nitric oxide regulates the size, quantity and quality of granuloma formation in Mycobacterium avium-infected mice without affecting bacterial loads. Immunology 98:313–323 [View Article][PubMed]
   [Google Scholar]
6. Fine P. E. 1989; The BCG story: lessons from the past and implications for the future. Rev Infect Dis 11:Suppl 2S353–S359 [View Article][PubMed]
   [Google Scholar]
7. Flaherty D. K., Vesosky B., Beamer G. L., Stromberg P., Turner J. 2006; Exposure to Mycobacterium avium can modulate established immunity against Mycobacterium tuberculosis infection generated by Mycobacterium bovis BCG vaccination. J Leukoc Biol 80:1262–1271 [View Article][PubMed]
   [Google Scholar]
8. Flynn J. L., Goldstein M. M., Chan J., Triebold K. J., Pfeffer K., Lowenstein C. J., Schreiber R., Mak T. W., Bloom B. R. 1995; Tumor necrosis factor-α is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2:561–572 [View Article][PubMed]
   [Google Scholar]
9. Folch J., Lees M., Sloane Stanley G. H. 1957; A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226:497–509[PubMed]
   [Google Scholar]
10. Fortier A. H., Hoover D. L., Nacy C. A. 1982; Intracellular replication of Leishmania tropica in mouse peritoneal macrophages: amastigote infection of resident cells and inflammatory exudate macrophages. Infect Immun 38:1304–1308[PubMed]
    [Google Scholar]
11. Gao H., Yue Y., Hu L., Xu W., Xiong S. 2009; A novel DNA vaccine containing multiple TB-specific epitopes casted in a natural structure (ECANS) confers protective immunity against pulmonary mycobacterial challenge. Vaccine 27:5313–5319 [View Article][PubMed]
    [Google Scholar]
12. Horgen L., Barrow E. L., Barrow W. W., Rastogi N. 2000; Exposure of human peripheral blood mononuclear cells to total lipids and serovar-specific glycopeptidolipids from Mycobacterium avium serovars 4 and 8 results in inhibition of TH1-type responses. Microb Pathog 29:9–16 [View Article][PubMed]
    [Google Scholar]
13. Howard C. J., Kwong L. S., Villarreal-Ramos B., Sopp P., Hope J. C. 2002; Exposure to Mycobacterium avium primes the immune system of calves for vaccination with Mycobacterium bovis BCG. Clin Exp Immunol 130:190–195 [View Article][PubMed]
    [Google Scholar]
14. Lafuse W. P., Alvarez G. R., Curry H. M., Zwilling B. S. 2006; Mycobacterium tuberculosis and Mycobacterium avium inhibit IFN-γ-induced gene expression by TLR2-dependent and independent pathways. J Interferon Cytokine Res 26:548–561 [View Article][PubMed]
    [Google Scholar]
15. MacMicking J. D., Taylor G. A., McKinney J. D. 2003; Immune control of tuberculosis by IFN-γ-inducible LRG-47. Science 302:654–659 [View Article][PubMed]
    [Google Scholar]
16. Martins D. R., Pelizon A. C., Zorzella-Pezavento S. F., Seger J., Santos Junior R. R., Fonseca D. M., Justulin L. A. Jr, Silva C. L., Sartori A. 2011; Exposure to Mycobacterium avium decreases the protective effect of the DNA vaccine pVAXhsp65 against Mycobacterium tuberculosis-induced inflammation of the pulmonary parenchyma. Scand J Immunol 73:293–300 [View Article][PubMed]
    [Google Scholar]
17. Mendoza-Coronel E., Camacho-Sandoval R., Bonifaz L. C., López-Vidal Y. 2011; PD-L2 induction on dendritic cells exposed to Mycobacterium avium downregulates BCG-specific T cell response. Tuberculosis (Edinb) 91:36–46 [View Article][PubMed]
    [Google Scholar]
18. Olleros M. L., Vesin D., Bisig R., Santiago-Raber M. L., Schuepbach-Mallepell S., Kollias G., Gaide O., Garcia I. 2012; Membrane-bound TNF induces protective immune responses to M. bovis BCG infection: regulation of memTNF and TNF receptors comparing two memTNF molecules. PLoS ONE 7:e31469 [View Article][PubMed]
    [Google Scholar]
19. Roger P. M., Bermudez L. E. 2001; Infection of mice with Mycobacterium avium primes CD8⁺ lymphocytes for apoptosis upon exposure to macrophages. Clin Immunol 99:378–386 [View Article][PubMed]
    [Google Scholar]
20. Sangari F. J., Petrofsky M., Bermudez L. E. 1999; Mycobacterium avium infection of epithelial cells results in inhibition or delay in the release of interleukin-8 and RANTES. Infect Immun 67:5069–5075[PubMed]
    [Google Scholar]
21. Silva R. A., Pais T. F., Appelberg R. 2001; Blocking the receptor for IL-10 improves antimycobacterial chemotherapy and vaccination. J Immunol 167:1535–1541[PubMed] [CrossRef]
    [Google Scholar]
22. Sweet L., Singh P. P., Azad A. K., Rajaram M. V., Schlesinger L. S., Schorey J. S. 2010; Mannose receptor-dependent delay in phagosome maturation by Mycobacterium avium glycopeptidolipids. Infect Immun 78:518–526 [View Article][PubMed]
    [Google Scholar]
23. Tsuyuguchi I., Kawasumi H., Takashima T., Tsuyuguchi T., Kishimoto S. 1990; Mycobacterium avium-Mycobacterium intracellulare complex-induced suppression of T-cell proliferation in vitro by regulation of monocyte accessory cell activity. Infect Immun 58:1369–1378[PubMed]
    [Google Scholar]
24. Van Rhijn I., Nguyen T. K., Michel A., Cooper D., Govaerts M., Cheng T. Y., van Eden W., Moody D. B., Coetzer J. A. et al. 2009; Low cross-reactivity of T-cell responses against lipids from Mycobacterium bovis and M. avium paratuberculosis during natural infection. Eur J Immunol 39:3031–3041 [View Article][PubMed]
    [Google Scholar]
25. Wagner D., Sangari F. J., Kim S., Petrofsky M., Bermudez L. E. 2002; Mycobacterium avium infection of macrophages results in progressive suppression of interleukin-12 production in vitro and in vivo . J Leukoc Biol 71:80–88[PubMed]
    [Google Scholar]
26. WHO 2008 WHO Vaccine-Preventable Diseases: Monitoring System 2008 Global Summary pp. 1–333 Geneva: WHO;
    [Google Scholar]
27. WHO 2009 Global Tuberculosis Control: Epidemiology, Strategy, Financing Geneva: WHO;
    [Google Scholar]
28. Yang D., Liu Y., Chen Y., Jiao D., Hou X., Wang L., Fu N. 2012; Pretreatment with Mycobacterium avium-derived lipids attenuates the response of murine macrophages to components of Mycobacterium tuberculosis . Int J Mol Med 29:1072–1082[PubMed]
    [Google Scholar]
29. Zhang X., Goncalves R., Mosser D. M. 2008; The isolation and characterization of murine macrophages. Curr Protoc Immunol 8314.1.1–14.1.14 [View Article]
    [Google Scholar]
30. Zhong J., Gilbertson B., Cheers C. 2003; Apoptosis of CD4⁺ and CD8⁺ T cells during experimental infection with Mycobacterium avium is controlled by Fas/FasL and Bcl-2-sensitive pathways, respectively. Immunol Cell Biol 81:480–486 [View Article][PubMed]
    [Google Scholar]